Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 235

1.

Transient hypogonadotropic hypogonadism caused by critical illness.

Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M.

J Clin Endocrinol Metab. 1985 Mar;60(3):444-50.

PMID:
3919042
3.

A study of the endocrine manifestations of hepatic cirrhosis.

Baker HW, Burger HG, de Kretser DM, Dulmanis A, Hudson B, O'Connor S, Paulsen CA, Purcell N, Rennie GC, Seah CS, Taft HP, Wang C.

Q J Med. 1976 Jan;45(177):145-78.

PMID:
769039
4.

Both hyper- and hypogonadotropic hypogonadism occur transiently in acute illness: bio- and immunoactive gonadotropins.

Spratt DI, Bigos ST, Beitins I, Cox P, Longcope C, Orav J.

J Clin Endocrinol Metab. 1992 Dec;75(6):1562-70.

PMID:
1464665
5.

Transient hypogonadotrophic hypogonadism after head trauma: effects on steroid precursors and correlation with sympathetic nervous system activity.

Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M.

Clin Endocrinol (Oxf). 1986 Sep;25(3):265-74.

PMID:
3098464
6.
7.

Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.

van den Berghe G, Weekers F, Baxter RC, Wouters P, Iranmanesh A, Bouillon R, Veldhuis JD.

J Clin Endocrinol Metab. 2001 Jul;86(7):3217-26.

PMID:
11443192
8.

Fasting suppresses pulsatile luteinizing hormone (LH) secretion and enhances orderliness of LH release in young but not older men.

Bergendahl M, Aloi JA, Iranmanesh A, Mulligan TM, Veldhuis JD.

J Clin Endocrinol Metab. 1998 Jun;83(6):1967-75.

PMID:
9626127
9.

Hypogonadotropic hypogonadism: hormonal responses to low dose pulsatile administration of gonadotropin-releasing hormone.

Valk TW, Corley KP, Kelch RP, Marshall JC.

J Clin Endocrinol Metab. 1980 Oct;51(4):730-8.

PMID:
6774991
11.
12.
13.
14.

Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome.

Radicioni AF, Di Giorgio G, Grugni G, Cuttini M, Losacco V, Anzuini A, Spera S, Marzano C, Lenzi A, Cappa M, Crinò A.

Clin Endocrinol (Oxf). 2012 Jan;76(1):72-7. doi: 10.1111/j.1365-2265.2011.04161.x.

PMID:
21718342
15.

Differences between men and women as regards the effects of protein-energy malnutrition on the hypothalamic-pituitary-gonadal axis.

Lado-Abeal J, Prieto D, Lorenzo M, Lojo S, Febrero M, Camarero E, Cabezas-Cerrato J.

Nutrition. 1999 May;15(5):351-8.

PMID:
10355847
16.

Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.

Pavlou SN, Wakefield G, Schlechter NL, Lindner J, Souza KH, Kamilaris TC, Konidaris S, Rivier JE, Vale WW, Toglia M.

J Clin Endocrinol Metab. 1989 Feb;68(2):446-54.

PMID:
2537334
17.

Partial reversal of the hypogonadotropic hypogonadism of obese men by administration of corticosuppressive doses of dexamethasone.

Zumoff B, Strain GW, Miller LK, Rosner W, Levit CD, Miller EH, Rosenfeld RS.

Int J Obes. 1988;12(6):525-31.

PMID:
3148562
18.

Evaluation of the hypothalamic-pituitary-gonadal axis in eugonadal men with type 2 diabetes mellitus.

Costanzo PR, Suárez SM, Scaglia HE, Zylbersztein C, Litwak LE, Knoblovits P.

Andrology. 2014 Jan;2(1):117-24. doi: 10.1111/j.2047-2927.2013.00163.x. Epub 2013 Nov 26.

19.
20.

Evidence for decreased luteinizing hormone-releasing hormone pulse frequency in men with selective elevations of follicle-stimulating hormone.

Gross KM, Matsumoto AM, Southworth MB, Bremner WJ.

J Clin Endocrinol Metab. 1985 Jan;60(1):197-202.

PMID:
3917266

Supplemental Content

Support Center